Concepedia

Miriam Canavese

MC

8

Publications

795

Citations

8

H-Index

2010

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

University of Perugia

Massachusetts General Hospital

University of Turin

Miriam Canavese is an author at Dana-Farber Cancer Institute specializing in immunology, medicine, and inflammation.

Top concepts

Publications per year

2010–2023

8

Publications

8

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

Loredana Santo, Teru Hideshima, Andrew L. Kung et al. · Blood · 2012 · 594 citations · Full text

Preclinical Activity of the Oral Proteasome Inhibitor MLN9708 in Myeloma Bone Disease

Antonio García-Gómez, Dalia Quwaider, Miriam Canavese et al. · Clinical Cancer Research · 2014 · 85 citations

Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease

Jey M Jeyakumar, Azadeh Kia, Lawrence C. S. Tam et al. · Gene Therapy · 2023 · 36 citations · Full text

Therapeutic Efficacy and Immunological Response of CCL5 Antagonists in Models of Contact Skin Reaction

Miriam Canavese, Fiorella Altruda, Lorenzo Silengo · PLoS ONE · 2010 · 24 citations · Full text

, , +18

Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.

Miriam Canavese, Fiorella Altruda, Lorenzo Silengo et al. · PubMed · 2011 · 18 citations

, , +14

Rows per page

1–5 of 8